tirzepatide fda decision approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Closest medical alternatives to tirzepatide:
Description
A study of 72 adults with obesity found that those with the highest added sugar intake experienced the smallest increase in GLP-1 levels following glucose consumption
Now, theres a natural GLP-1 alternative that mimics many of the same benefits without requiring a prescription
Not vague reassurance
LDL Cholesterol What it measures: "Bad" cholesterol the particles that deposit in arterial walls
Conclusion In simple terms, Tirzepatide shows a lot of hope for weight loss based on clinical trials
10.1056/NEJMoa1503780 15
